Prestige Consumer Healthcare
PBH
#4612
Rank
HK$17.81 B
Marketcap
HK$376.05
Share price
-0.48%
Change (1 day)
-43.51%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): HK$31.40

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is HK$31.57. In 2024 the company made an earnings per share (EPS) of HK$33.69 an increase over its 2023 EPS that were of -HK$12.61.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$31.40-6.78%
2024HK$33.69-367.08%
2023-HK$12.61-138.33%
2022HK$32.9011.7%
2021HK$29.4613.6%
2020HK$25.93-651.67%
2019-HK$4.70-148.78%
2018HK$9.64-83.29%
2017HK$57.66437.23%
2016HK$10.73-34.13%
2015HK$16.3052.94%
2014HK$10.65-8.11%
2013HK$11.59
2011HK$6.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.44 116.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
HK$54.76 73.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$55.00 74.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.26-67.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$28.27-10.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
HK$48.42 53.35%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
HK$18.10-42.68%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$30.45-3.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
-HK$232.05-834.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
HK$9.56-69.73%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel